Screener
Nurix Therapeutics, Inc. NRIX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | May 31,2026 | November 30,2025 |
|---|---|---|
| Stockholdersʼ equity: | ||
| Preferred stock, $0.001 par value— 10,000,000 shares authorized as of May 31, 2026 and November 30, 2025; no shares issued and outstanding as of May 31, 2026 and November 30, 2025 | — | — |
| Common stock, $0.001 par value— 500,000,000 shares authorized as of May 31, 2026 and November 30, 2025; 103,701,511 and 101,807,484 shares issued and outstanding as of May 31, 2026 and November 30, 2025, respectively | 104 | 102 |
| Additional paid-in capital | 1,582,603 | 1,541,766 |
| Accumulated other comprehensive income (loss) | (145) | 105 |
| Accumulated deficit | (1,179,935) | (1,003,226) |
| Total stockholdersʼ equity | 402,627 | 538,747 |
| Total liabilities and stockholdersʼ equity | $535,540 | $688,135 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s total liabilities & equity?
- Nurix Therapeutics, Inc. (NRIX) reported total liabilities & equity of $535.54M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Nurix Therapeutics, Inc.'s total liabilities & equity decreased by 9.5% year-over-year, from $591.56M to $535.54M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s total liabilities & equity has grown at a 11.7% compound annual growth rate (CAGR), from $396.34M to $688.14M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Nurix Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude